TLDR
- AirSculpt reports $151.8M 2025 revenue and seeks short 10-K filing extension
- AIRS posts Q4 revenue of $33.4M while same-store sales decline
- Updated marketing strategy lifts comparable sales in February 2026
- Company projects Q1 2026 revenue between $38.5M and $39.5M
- AirSculpt reports $13M cash and $46M debt amid revenue stabilization
AirSculpt Technologies, Inc. (AIRS) stock trades near $4.60 as the company announced a filing delay for its annual report. The company plans to submit a Form 12b-25 to request a fifteen-day extension for its fiscal 2025 Form 10-K filing. Management released preliminary revenue metrics and current sales trends.
AirSculpt Technologies, Inc., AIRS
The filing extension provides additional time to complete classification of inter-company transactions and balances. The company expects to submit the final annual report within the permitted grace period. The extension follows Rule 12b-25 under the Securities Exchange Act.
AirSculpt operates a national network providing premium body contouring procedures. The company specializes in minimally invasive fat removal treatments and targeted body sculpting procedures. Its branded AirSculpt technology focuses on precision treatment and shorter recovery time.
AirSculpt Reports Preliminary 2025 Financial Results
AirSculpt reported preliminary fiscal 2025 revenue of approximately $151.8 million. Same-store revenue improved toward the end of the year despite remaining slightly negative in December. The improvement followed several operational and marketing adjustments implemented during 2025.
Fourth-quarter preliminary revenue reached about $33.4 million. Comparable same-store revenue declined about sixteen percent during the quarter. Despite this decline, management indicated improving sales trends near the end of the year.
The company described these results as preliminary because it has not completed year-end financial procedures. Final audited results may change after closing adjustments and internal accounting reviews. Therefore, the company expects to confirm final numbers in the upcoming Form 10-K filing.
Marketing Adjustments Drive Early 2026 Sales Momentum
AirSculpt introduced updated marketing initiatives aimed at increasing procedure demand. These adjustments focused on expanding outreach and promoting additional cosmetic procedures. As a result, the company recorded positive comparable sales during February 2026.
Management expects first-quarter 2026 revenue between $38.5 million and $39.5 million. At the midpoint of that guidance, same-store revenue appears approximately flat year over year. The company views this trend as early stabilization following prior demand softness.
The company also continues expanding service offerings into adjacent aesthetic procedures. This strategy aims to broaden the patient base and increase treatment volume. Operational adjustments also support efficiency and stronger patient scheduling.
Liquidity Position and Operational Context
AirSculpt reported cash holdings of approximately $13.0 million as of March 13, 2026. At the same time, the company reported total debt of about $46.0 million. These figures reflect the firm’s current liquidity position during the reporting period.
Management stated that operational changes helped strengthen sales performance entering 2026. Marketing recalibration and operational adjustments improved demand trends during recent months. These efforts contributed to improved revenue comparisons in February.
The company continues positioning its treatment platform within the premium cosmetic procedure segment. AirSculpt procedures remove fat while tightening surrounding skin through minimally invasive techniques. Patients typically experience faster recovery, minimal bruising, and precise contouring results.
AirSculpt remains focused on expanding procedure demand while improving operational efficiency. The company aims to finalize its annual financial report during the extension period. Meanwhile, preliminary financial metrics suggest stabilization as the company moves through early 2026.


